These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 16718625)
1. Association between functional FABP2 promoter haplotype and type 2 diabetes. Li Y; Fisher E; Klapper M; Boeing H; Pfeiffer A; Hampe J; Schreiber S; Burwinkel B; Schrezenmeir J; Döring F Horm Metab Res; 2006 May; 38(5):300-7. PubMed ID: 16718625 [TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes-associated fatty acid binding protein 2 promoter haplotypes are differentially regulated by GATA factors. Klapper M; Böhme M; Nitz I; Döring F Hum Mutat; 2008 Jan; 29(1):142-9. PubMed ID: 17960769 [TBL] [Abstract][Full Text] [Related]
3. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Fisher E; Li Y; Burwinkel B; Kühr V; Hoffmann K; Möhlig M; Spranger J; Pfeiffer A; Boeing H; Schrezenmeir J; Döring F Horm Metab Res; 2006 May; 38(5):341-5. PubMed ID: 16718632 [TBL] [Abstract][Full Text] [Related]
4. Association between functional FABP2 promoter haplotypes and body mass index: analyses of 8072 participants of the KORA cohort study. Böhme M; Grallert H; Klapper M; Gieger C; Fischer A; Heid I; Wichmann HE; Döring F; Illig T Mol Nutr Food Res; 2009 Jun; 53(6):681-5. PubMed ID: 19156719 [TBL] [Abstract][Full Text] [Related]
5. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Vimaleswaran KS; Radha V; Mohan V Metabolism; 2006 Sep; 55(9):1222-6. PubMed ID: 16919542 [TBL] [Abstract][Full Text] [Related]
6. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Albala C; Villarroel A; Santos JL; Angel B; Lera L; Liberman C; Sanchez H; Pérez-Bravo F Diabetes Res Clin Pract; 2007 Aug; 77(2):245-50. PubMed ID: 17292994 [TBL] [Abstract][Full Text] [Related]
7. The effects of retinol on postprandial parameters in men with different FABP2 promoter haplotypes. Helwig U; Rubin D; Kiosz J; Bitter W; Schreiber S; Döring F; Fölsch UR; Schrezenmeir J Horm Metab Res; 2007 Apr; 39(4):237-43. PubMed ID: 17447159 [TBL] [Abstract][Full Text] [Related]
8. The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability. Helwig U; Rubin D; Klapper M; Li Y; Nothnagel M; Fölsch UR; Döring F; Schreiber S; Schrezenmeir J Metabolism; 2007 Jun; 56(6):723-31. PubMed ID: 17512303 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700 [TBL] [Abstract][Full Text] [Related]
10. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2. De Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; De la Fuente B Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):89-95. PubMed ID: 20329566 [TBL] [Abstract][Full Text] [Related]
11. Association of the FABP2 Ala54Thr polymorphism with type 2 diabetes, obesity, and metabolic syndrome: a population-based case-control study and a systematic meta-analysis. Liu Y; Wu G; Han L; Zhao K; Qu Y; Xu A; Huang Q Genet Mol Res; 2015 Feb; 14(1):1155-68. PubMed ID: 25730055 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431 [TBL] [Abstract][Full Text] [Related]
13. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease. Aller R; De Luis DA; Fernandez L; Calle F; Velayos B; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez JM Eur Rev Med Pharmacol Sci; 2009; 13(5):357-64. PubMed ID: 19961041 [TBL] [Abstract][Full Text] [Related]
14. Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population. Gouni-Berthold I; Giannakidou E; Faust M; Kratzsch J; Berthold HK; Krone W J Intern Med; 2005 Dec; 258(6):518-26. PubMed ID: 16313475 [TBL] [Abstract][Full Text] [Related]
15. L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Fisher E; Weikert C; Klapper M; Lindner I; Möhlig M; Spranger J; Boeing H; Schrezenmeir J; Döring F Mol Genet Metab; 2007 Jul; 91(3):278-84. PubMed ID: 17485234 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome. Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300 [TBL] [Abstract][Full Text] [Related]
17. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Qi L; van Dam RM; Meigs JB; Manson JE; Hunter D; Hu FB Hum Mol Genet; 2006 Jun; 15(11):1914-20. PubMed ID: 16644865 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis on the effect of the Ala54Thr polymorphism of the fatty acid-binding protein 2 gene on body mass index. Zhao T; Zhao J; Lv J; Nzekebaloudou M Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):823-9. PubMed ID: 20621703 [TBL] [Abstract][Full Text] [Related]
19. Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population. Duarte NL; Colagiuri S; Palu T; Wang XL; Wilcken DE Mol Genet Metab; 2003 Jul; 79(3):183-8. PubMed ID: 12855223 [TBL] [Abstract][Full Text] [Related]
20. IKBL promoter polymorphism is strongly associated with resistance to type 1 diabetes in Japanese. Yamashita T; Hamaguchi K; Kusuda Y; Kimura A; Sakata T; Yoshimatsu H Tissue Antigens; 2004 Mar; 63(3):223-30. PubMed ID: 14989711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]